drugset / Trial / NCT06949904
The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this study is to compare the mean length of hospital stay between children with pneumonia receiving melatonin as an adjuvant therapy and those receiving standard of care alone. The hypothesis is that combining oral melatonin with standard treatment can reduce the length of hospital stay as compared to standard of care alone. The control group will receive standard treatment (antibiotic) while the intervention group will receive standard treatment plus melatonin for 14 days.
Timeline
- Start
- 2025-05
- Primary completion
- 2025-12
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 1 mg | Oral |
| Subject | Melatonin | Small molecule | 2.5 mg | Oral |
| Subject | Melatonin | Small molecule | 3 mg | Oral |